Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gene Expression in Ankylosing Spondylitis Treated with Infliximab
NCT00778869Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2005
- Primary completion
- Aug 2005
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of infliximab in ankylosing spondylitis (AS), sponsored by Merck & Co.. Started Aug 2005; status: completed.
02
Drugs
infliximab
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00778869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00778869.